Schedule 13G ownership disclosure

Olema Pharmaceuticals Inc

Security class unavailable · CUSIP: 68062P106

Event date: 2024-06-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,225,250
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-004309
Form type
SC 13G
Filer
Olema Oncology, Inc.
CIK
CIK 1750284
Filed
Jun 14, 2024
Reporting period
Jun 04, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub